Loading…
Novanta Inc. is projected to rise to $184.86 by 2027, a +33% move from its current price of $138.91. NOVT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $136.07 | $138.94 | $141.87 | +0.02% |
| Aug 2 | $134.93 | $138.97 | $143.13 | +0.04% |
| Aug 3 | $134.06 | $139.00 | $144.11 | +0.06% |
| Aug 4 | $133.34 | $139.02 | $144.95 | +0.08% |
| Aug 5 | $132.71 | $139.05 | $145.69 | +0.10% |
| Aug 6 | $132.15 | $139.08 | $146.38 | +0.12% |
| Aug 7 | $131.64 | $139.11 | $147.01 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $131.64 | $139.11 | $147.01 | +0.14% |
| Week 2 | $128.85 | $139.31 | $150.62 | +0.29% |
| Week 3 | $126.79 | $139.51 | $153.51 | +0.43% |
| Week 4 | $125.11 | $139.71 | $156.02 | +0.58% |
| Week 5 | $123.67 | $139.92 | $158.30 | +0.72% |
| Week 6 | $122.39 | $140.12 | $160.41 | +0.87% |
| Week 7 | $121.25 | $140.32 | $162.39 | +1.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles.
This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc.
and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Novanta Inc. (NOVT) currently trades at $143.55 per share and has a market cap of $5.11B. It ranks 1275 by market capitalization. The current price and market position establish a base for a multi-year forecast that envisions a rising price trajectory.
A major floor 18.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.8% away) — a key level to hold.
The nearest ceiling, 18.7% above — a clean break opens room to run.
A major ceiling 25.5% above — clearing it would confirm fresh momentum.
Key NOVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NOVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $140.13 | Sell | $140.26 | Sell |
| MA 10 | $142.73 | Sell | $142.58 | Sell |
| MA 20 | $147.58 | Sell | $146.22 | Sell |
| MA 50 | $154.26 | Sell | $148.39 | Sell |
| MA 100 | $141.03 | Sell | $144.17 | Sell |
| MA 200 | $132.75 | Buy | $138.11 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.95 | Neutral |
| Stoch RSI (14) | 19.06 | Buy |
| CCI (20) | -112.56 | Sell |
| Williams %R (14) | -90.51 | Info |
| MACD (12,26,9) | -0.96 | Sell |
| ROC (12) | -5.26 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 9.49 | Buy |
| TRIX (15) | -0.31 | Sell |
| Awesome (5,34) | -11.45 | Sell |
| Ultimate (7,14,28) | 22.55 | Buy |
| Momentum (10) | -10.76 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 138.20 | Buy |
| ADX (14) | 16.56 | Neutral |
| ATR (14) | 2.80 | Info |
From a technical perspective, the 30-day picture is labeled bullish. The RSI14 sits at 40, with the 50-day simple moving average at $155.34 and the 200-day simple moving average at $131.19, indicating the stock is trading above longer-term support but below the near-term peak. The immediate support level is $143.55, with resistance at $164.89.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $111.14 | $138.91 | $192.21 | 0% | Neutral | |
| $150.58 | $184.86 | $237.86 | +33% | Bullish | |
| $168.57 | $211.35 | $280.14 | +52% | Bullish | |
| $171.47 | $218.72 | $296.74 | +57% | Bullish | |
| $188.13 | $243.63 | $337.08 | +75% | Bullish | |
| $212.51 | $278.99 | $392.70 | +101% | Bullish | |
| $232.42 | $309.03 | $441.75 | +122% | Bullish | |
| $278.02 | $374.06 | $542.27 | +169% | Bullish | |
| $303.34 | $412.71 | $606.10 | +197% | Bullish | |
| $299.92 | $412.43 | $613.02 | +197% | Bullish | |
| $456.60 | $658.56 | $1,029.89 | +374% | Bullish | |
| $823.92 | $1,287.19 | $2,169.56 | +827% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $111.14 | $138.91 | $161.85 | +0.00% |
| August 2026 | $119.09 | $139.07 | $165.68 | +0.12% |
| September 2026 | $120.44 | $141.54 | $170.38 | +1.78% |
| October 2026 | $126.47 | $149.40 | $181.31 | +5.55% |
| November 2026 | $130.32 | $154.59 | $188.85 | +3.48% |
| December 2026 | $131.34 | $156.39 | $192.21 | +1.17% |
Click any year to see its month-by-month NOVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NOVT price prediction for 2026 points to an average of $138.91 (low $111.14, high $192.21) — a potential gain of 0% on today's $138.91. Price action looks broadly range-bound.
In 2027, NOVT is projected to trade between $150.58 and $237.86, averaging $184.86 — a potential gain of +33% from today's $138.91. That is up +33% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Novanta Inc.'s 2028 outlook centres on $211.35, within a $168.57 to $280.14 range. That is up +14% on the projected 2027 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2029, NOVT could reach as high as $296.74, with a base case around $218.72 and support toward $171.47 — roughly +57% from $138.91. Buyers look set to stay in control over this stretch.
Expect NOVT to range from $188.13 to $337.08 through 2030. The $243.63 average target implies a +75% move from current prices. That is up +11% on the projected 2029 average. Momentum favours further upside here.
The NOVT price prediction for 2031 points to an average of $278.99 (low $212.51, high $392.70) — a potential gain of +101% on today's $138.91. Buyers look set to stay in control over this stretch.
In 2032, NOVT is projected to trade between $232.42 and $441.75, averaging $309.03 — a potential gain of +122% from today's $138.91. That is up +11% on the projected 2031 average. Momentum favours further upside here.
Novanta Inc.'s 2033 outlook centres on $374.06, within a $278.02 to $542.27 range. That is up +21% on the projected 2032 average. That marks a +169% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NOVT could reach as high as $606.10, with a base case around $412.71 and support toward $303.34 — roughly +197% from $138.91. Momentum favours further upside here.
Expect NOVT to range from $299.92 to $613.02 through 2035. The $412.43 average target implies a +197% move from current prices. That is 0% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The NOVT price prediction for 2040 points to an average of $658.56 (low $456.60, high $1,029.89) — a potential gain of +374% on today's $138.91. Momentum favours further upside here.
In 2050, NOVT is projected to trade between $823.92 and $2,169.56, averaging $1,287.19 — a potential gain of +827% from today's $138.91. That is up +95% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NOVT today (≈ 7.198906 NOVT) could be worth
$9,266.33
+$8,266.33 (+827%) by 2050 · US Dollar
Based on the average projected NOVT price of $1,287.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NOVTwould be worth at today's price.
$1,000 invested in NOVT on Jul 30, 2025 (≈ 8.114249 NOVT) would be worth
$1,127.15
+$127.15 (+12.7%) today · 1.13× · US Dollar
Based on a NOVT entry price of $123.24 vs. today's $138.91.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $143.26 | $969.64 | -3.0% |
| 1 month ago | $162.24 | $856.2 | -14.4% |
| 3 months ago | $127.87 | $1,086.34 | +8.6% |
| 6 months ago | $134.54 | $1,032.48 | +3.2% |
| 1 year ago | $123.24 | $1,127.15 | +12.7% |
| All time (5.0y) ago | $138.97 | $999.57 | -0.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NOVT forecast.
Our base-case forecast reaches $280.00 around 2032.
Implied market cap at $280.00: $9.97B
The multi-year forecast shows a clear upward trajectory after 2026. The 2026 average is $143.55 with a range from $111.14 to $204.03 and a 0% ROI, indicating a flat start relative to the current price. In 2027 the average rises to $193.66 (ROI 34.9%) and the sentiment remains bullish.
By 2030 the average is $248.59 (ROI 73.2%), continuing a bullish trend. The forecast extends to 2040 with an average of $649.59 (ROI 352.5%) and to 2050 with an average of $1,268.93 (ROI 784%), with a max of $2,275.37. Across these years, the sentiment is consistently bullish, reflecting strong upside potential within the provided estimates.
These are estimates, not guarantees, and actual results will depend on market conditions and company performance.
Tap a question to reveal the answer.
The 2030 forecast lists an average of $248.59 with a min of $186.90 and a max of $355.50, and a projected ROI of 73.2% with bullish sentiment.
The forecast shows a bullish sentiment from 2027 onward with rising averages and positive ROI (e.g., 34.9% in 2027, 73.2% in 2030, up to 784% by 2050). These are estimates and not guarantees.
Yes. The 2040 max is $1,069.71 and the 2050 max is $2,275.37, indicating potential to surpass $1,000 in the forecast period.
Current price is $143.55 and market cap is $5.11B.
The 2050 forecast shows an average of $1,268.93 with a max of $2,275.37 and a ROI of 784%, with bullish sentiment.
Novanta Inc. Community Discussion
0Share your Novanta Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.